Insights

In a world of disruption and constant change, where ambiguity is the norm, we actively drive
conversations as thought leaders across multiple industries to generate insights that lead to
pragmatic outcomes.

Chief Patient Officer at Pfizer, Dr. Dara Richardson-Heron, Joins Merryck & Co.

Chief Patient Officer at Pfizer, Dr. Dara Richardson-Heron, Joins Merryck & Co.

(New York, NY) March 24, 2021 – Merryck & Co., a global executive coaching and mentoring firm, is pleased to announce that Dr. Dara Richardson-Heron, Chief Patient Officer at Pfizer, Inc., has joined its growing cadre of executive mentors.

Dr. Dara Richardson-Heron is a distinguished Fortune 100 corporate executive, board director and physician with over 25 years of leadership excellence in healthcare, corporate and non-profit sectors. A frequent speaker on equity in medicine and women in leadership, Dr. Richardson-Heron is known for her transformative contributions to improving disparities in healthcare and the workplace.

“Dara’s experiences as a top executive, as well as the role she played in the pandemic response, bring a unique and impactful background to Merryck,” remarked David Reimer, CEO of Merryck & Co. Americas. “We are confident she will greatly benefit our clients.”

In addition to her work at Merryck, Dr. Richardson-Heron serves as Chief Patient Officer at Pfizer, Inc., one of the world’s largest pharmaceutical companies. She is responsible for the organization’s global strategy to advance patient-focused programs and platforms. In addition, Dr. Richardson-Heron is responsible for identifying, creating and amplifying a strategic framework for impactful interactions with the organization’s patients in over 180 countries worldwide.

“Dara’s experiences as a top executive, as well as the role she played in the pandemic response, bring a unique and impactful background to Merryck.”

Before joining Pfizer, Dr. Richardson-Heron served as the chief engagement officer and scientific executive for the National Institutes of Health’s (NIH) All of Us Research Program. There, she served on the NIH executive leadership team and led outreach efforts to enroll and retain over 1 million volunteers in a landmark effort to advance diverse and innovative health research that may lead to more precise treatment and prevention strategies.

Dr. Richardson-Heron served as CEO of the YWCA USA where she led the 158-year-old organization‘s transformation, mission impact, member services, advocacy, communications, finance, development teams and field directors nationwide. Together with her executive leadership team, she worked to develop and implement innovative, value added solutions and supports for the 25th largest nonprofit in the United States with a network of more than 220 local association members with net assets of nearly $1 Billion offering life-changing community-based services.

Previously, she served as the CEO of the Greater NYC Affiliate of Susan G. Komen for the Cure, national chief medical officer at the United Cerebral Palsy Association, assistant executive director and chief medical officer at United Cerebral Palsy of New York City, and special assistant to the CEO and executive medical director at Consolidated Edison Company of New York, Inc.